An Open Label Phase I Placebo Controlled, Dose Escalation Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
Phase of Trial: Phase I
Latest Information Update: 25 Jun 2013
At a glance
- Drugs OC 10X (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- 25 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jun 2013 New trial record